O OncoMed Pharmaceuticals Inc: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of OncoMed Pharmaceuticals Inc, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 12 January 2016 (Levée d'options). Among the most active insiders: Dupont Jakob. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 12 January 2016
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
◇ SVP & Chief Medical Officer · Executives · 11 Jan 2016
2,500 shares Common Stock SEC:0001140361-16-047651:0
▼ SVP & Chief Medical Officer · Executives · 11 Jan 2016
2,500 shares Common Stock SEC:0001140361-16-047651:1
▼ SVP & Chief Medical Officer · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047340:0
▼ SVP & Chief Medical Officer · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047340:1
▼ SVP & Chief Medical Officer · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047340:2
▼ See Remarks · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047339:0
▼ See Remarks · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047339:1
▼ See Remarks · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047339:2
▼ Chairman & CEO · Executives · 6 Jan 2016
2,335 shares Common Stock SEC:0001140361-16-047336:0
▼ Chairman & CEO · Executives · 6 Jan 2016
77 shares Common Stock SEC:0001140361-16-047336:1
▼ VP & General Counsel · Executives · 6 Jan 2016
1,570 shares Common Stock SEC:0001140361-16-047335:0
▼ VP & General Counsel · Executives · 6 Jan 2016
52 shares Common Stock SEC:0001140361-16-047335:1
▼ VP & General Counsel · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047335:2
▼ SVP, Cancer Biology · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047337:0
▼ SVP, Cancer Biology · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047337:1
▼ SVP, Cancer Biology · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047337:2
▼ EVP & Chief Scientific Officer · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047333:0
▼ EVP & Chief Scientific Officer · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047333:1
▼ EVP & Chief Scientific Officer · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047333:2
▼ See Remarks · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047334:0
▼ See Remarks · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047334:1
▼ See Remarks · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047334:2